Brief: Stayble Therapeutics Appoints Erik Kullgren As CFO
July 23 (Reuters) - Stayble Therapeutics AB STABL.ST :
* ERIK KULLGREN HAS BEEN APPOINTED AS NEW CFO WITH EFFECT
FROM 1
AUGUST 2024
Source text for Eikon: ID:nWkr1q9cyx
Further company coverage: STABL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Stayble Therapeutics AB
See all newsBrief: Stayble Therapeutics Delisted From Nasdaq First North Growth Market
Brief: Stayble Therapeutics To Apply For Bankruptcy
Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 6.9 Mln
Brief: Stayble Therapeutics Enters Into LoI On Potential Strategic Collaboration, Financing
Brief: Stayble Therapeutics Q4 Oper Loss To SEK 1.5 Mln